Navigation Links
MDS Pharma Services Wins Award for Management of Global Malaria Trial
Date:9/7/2007

KING OF PRUSSIA, PA, Sept. 7 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has won the Good Clinical Practice Journal (GCPj) Award for the clinical research program that best promotes access to new medicines. This award is one of a series of inaugural GCPj awards introduced this year to recognize excellence in clinical research. MDS Pharma Services received this award during a ceremony in London where it was recognized for its successful management of a large-scale Phase III malaria drug trial involving more than 2,700 patients in Laos, India, Thailand, Burkina Faso, Kenya, Mozambique, Uganda, and Zambia.

The compound studied by MDS Pharma Services is relatively low-cost and has the potential to become a major breakthrough in the treatment of malaria, a deadly mosquito-borne disease prevalent in the world's poorest countries. According to the World Health Organization, malaria kills more than one million people each year and there are between 350 and 500 million clinical episodes of this disease occurring annually. This high incidence rate is fueled by malaria's growing resistance to existing drugs.

This malaria clinical trial was conducted by MDS Pharma Services on behalf of an international collaboration between Sigma-Tau, a leading pharmaceutical company based in Italy; the non-profit Medicines for Malaria Venture, which is supported by the Bill & Melinda Gates Foundation; China's Chongqing Holley pharmaceutical company; and Britain's Oxford University.

"At Sigma-Tau, we appreciate the challenges in carrying out a large global trial," said Sigma-Tau Medical Department Director Marco Corsi. "The successful completion of this trial was made possible by both the professionalism of the MDS people managing the trial and the personal commitment of all participants to improve the treatment of malaria - a neglected but deadly disease."

"We are really honoured by this recognition of MDS Pharma Services' role in the effort to find an easy-to-use, affordable and effective treatment for this devastating disease," said MDS Pharma Services President David Spaight. "Infectious diseases, such as HIV and malaria, are key pharmaceutical research areas that have the potential to benefit large numbers of patients around the world."

About MDS Pharma Services

MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at http://www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Pharma Services
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. India to benefit from pharma companies move
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharma cos must forge Strategic alliances
6. Setting up a new pharmaceutical industry in India
7. Medicis Pharmaceutical company enters pediatric market
8. Supply of Radiopharmaceuticals Hampered by Attacks
9. Pharma majors gear to supply anti-anthrax drug
10. Pharmacies in for a dose of bitter medicine
11. Andhra Pradesh to set up Pharma City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: